Glycinamide, N-[[[3-(2-sulfoethyl)phenyl]amino]carbonyl]glycyl-N2-(3-methoxyphenyl)-N-methyl-N-phenyl- (9CI) manufacturers
- RP73870
-
- $2180.00
-
2026-04-20
- CAS:197012-43-4
- Purity:
- Supply Ability: 10g
|
| | Glycinamide, N-[[[3-(2-sulfoethyl)phenyl]amino]carbonyl]glycyl-N2-(3-methoxyphenyl)-N-methyl-N-phenyl- (9CI) Basic information |
| | Glycinamide, N-[[[3-(2-sulfoethyl)phenyl]amino]carbonyl]glycyl-N2-(3-methoxyphenyl)-N-methyl-N-phenyl- (9CI) Chemical Properties |
| density | 1.391±0.06 g/cm3(Predicted) | | pka | 1.63±0.50(Predicted) |
| | Glycinamide, N-[[[3-(2-sulfoethyl)phenyl]amino]carbonyl]glycyl-N2-(3-methoxyphenyl)-N-methyl-N-phenyl- (9CI) Usage And Synthesis |
| Description | RP73870 is a H2 receptor antagonist and gastricholecystokinin-B receptor antagonist with potent anti-ulcer activity. | | Uses | RP73870 is an orally active gastrin/cholecystokinin-B receptor antagonist. RP73870 inhibits basal gastric acid secretion in the rat. RP73870 has potent anti-ulcer activity[1]. | | References | [1] Pendley CE, et al. RP 73870, a gastrin/cholecystokinin-B receptor antagonist with potent anti-ulcer activity in the rat. J Pharmacol Exp Ther. 1995 Jun;273(3):1015-22. PMID:7791071 |
| | Glycinamide, N-[[[3-(2-sulfoethyl)phenyl]amino]carbonyl]glycyl-N2-(3-methoxyphenyl)-N-methyl-N-phenyl- (9CI) Preparation Products And Raw materials |
|